Oraya Therapeutics Raises $15.875M
Newark, California-based Oraya Therapeutics, a developer of noninvasive, robotically controlled systems for treating eye disorders, has raised another $15.875M in funding, according to a regulatory filing by the firm. The round comes on $5.0M raised in December, for a total of $20.875M in its latest round. Details on the new funding have not been disclosed by the company. Oraya's products are aimed at treating wet age-related macular degeneration (AMD).
posted on Wednesday, April 6, 2011 (Link to more information)
Related companies:
Oraya Therapeutics
Related stories:
> Oraya Therapeutics Raises $42M
> Apropose Finds $1.875M For Better Web Design
> Arete Therapeutics Raises $35M
> Nuon Therapeutics Raises $27M
> Lead Therapeutics Raises $17M
silicontap.com Home